Search Options Stock News and Analysis from Schaeffer's

Gene Therapy Stock Moves Higher on Analyst Upgrade

https://www.schaeffersresearch.com/content/news/2020/07/07/gene-therapy-stock-moves-higher-on-analyst-upgrade

7/7/2020 10:13 AM

The shares of Sangamo Therapeutics Inc (NASDAQ:SGMO) are up 1.7% at $10 at last check, after moving higher on the charts in their last five-consecutive closes. Additionally, SunTrust Robinson just in...

SGMO Stock Runs Higher on Study Results

https://www.schaeffersresearch.com/content/news/2019/12/09/sgmo-stock-runs-higher-on-study-results

12/9/2019 9:22 AM

The shares of Sangamo Therapeutics Inc (NASDAQ:SGMO) are eyeing a three-month high of $12.25 today, up 5.1% at last check, after the firm shared promising results for its gene-editing therapy ST-40...

2 Biotech Stocks Starting the Week Off Strong

https://www.schaeffersresearch.com/content/news/2019/07/08/2-biotech-stocks-starting-the-week-off-strong

7/8/2019 9:53 AM

Two biotech names are making a run up the Nasdaq charts this morning. First there's Sangamo Therapeutics Inc (NASDAQ:SGMO), up 10% to trade at $12.53, after the gene therapy specialist reported positi...

Sangamo Therapeutics Bull Gap Fuels Hot Options Trading

https://www.schaeffersresearch.com/content/options/2019/04/02/sangamo-therapeutics-bull-gap-fuels-hot-options-trading

4/2/2019 12:43 PM

The shares of Sangamo Therapeutics Inc (NASDAQ:SGMO) are on fire, after the California-based biotech reported positive data in a phase 1/2 study for its gene therapy hemophilia treatment that's being...

Signal Says Sell This Biotech Stock

https://www.schaeffersresearch.com/content/analysis/2019/03/12/signal-says-sell-this-biotech-stock

3/12/2019 12:23 PM

Biotech company Sangamo Therapeutics Inc (NASDAQ:SGMO) just named Jason Fontenot, Ph.D. as its Senior Vice President, Cell Therapy. Fontenot will be in charge of the genomic medicine concern's develo...

PEOPLE ALSO SEARCH FOR